Explore groundbreaking cancer therapy outcomes for Medicare patients, highlighting pivotal studies on leukemia, lymphoma, and innovative treatments.

Explore Shilpa Biocare's partnership with Gate2Brain targeting pediatric brain cancers, improving drug delivery, and enhancing shareholder value for the future.

Join the REACH study in West Virginia focusing on advanced cancer detection for better outcomes and early diagnosis through innovative technology.

Explore the complex insurance barriers faced by foster children in accessing vital treatments like CAR T-cell therapy, highlighting legislative and healthcare challenges.

This article examines how health insurance affects cancer survival rates among young adults, highlighting disparities and calling for policy improvements.

Discover how CorMedix is advancing its initiatives and adapting to reimbursement changes in specialty pharmaceuticals at the Citizens Life Sciences Conference.

Explore the urgent call for regulatory flexibility in rare disease therapies, as industry leaders seek solutions to expedite drug approvals amid strict FDA guidelines.

Explore the challenges of patient enrollment in cancer clinical trials and how insurance reforms can improve accessibility for those in need.

Personalis updates valuation with a raised fair value to $11 per share driven by Medicare reimbursement for its NeXT Personal test and strong Q3 revenue performance. Analysts see durable revenue growth and clinical validation as key drivers.

Georgia man sentenced for $24M Medicare genetic testing kickback scheme; FDA warns on lead in cookware; new guidance limits primate testing in drug development.